menu search

VKTX / 1 Under-the-Radar Stock That Could Triple By 2030

1 Under-the-Radar Stock That Could Triple By 2030
Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in phase 2 clinical trials. Read More
Posted: Nov 4 2023, 07:30
Author Name: The Motley Fool
Views: 022759

VKTX News  

1 Under-the-Radar Stock That Could Triple By 2030

By The Motley Fool
November 4, 2023

1 Under-the-Radar Stock That Could Triple By 2030

Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in phase 2 cl more_horizontal

Why Is Viking Therapeutics (VKTX) Stock Moving Today?

By InvestorPlace
October 18, 2023

Why Is Viking Therapeutics (VKTX) Stock Moving Today?

Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. more_horizontal

Viking Therapeutics joins weight loss drug bandwagon as trial data impresses

By Proactive Investors
October 18, 2023

Viking Therapeutics joins weight loss drug bandwagon as trial data impresses

Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen more_horizontal

Viking Therapeutics' stock rallies following early drug study data

By Market Watch
October 17, 2023

Viking Therapeutics' stock rallies following early drug study data

Viking Therapeutics Inc. VKTX, -0.37% shares rose in the extended session Tuesday after the biotech drug developer said data from an early stage clini more_horizontal

Why Viking Therapeutics Is Plunging Today

By The Motley Fool
June 27, 2023

Why Viking Therapeutics Is Plunging Today

After positive mid-stage data, Eli Lilly seems to have a chance at achieving best-in-class status in the valuable weight loss market. Viking's shares more_horizontal

Why Viking Therapeutics Stock Is Crashing Today

By The Motley Fool
June 26, 2023

Why Viking Therapeutics Stock Is Crashing Today

A top competitor announced plans to move forward with a late-stage weight loss candidate today. Viking's weight-loss candidate is several years behind more_horizontal

Could Viking Therapeutics Stock Help You Become a Millionaire?

By The Motley Fool
June 17, 2023

Could Viking Therapeutics Stock Help You Become a Millionaire?

Viking Therapeutics has a few drugs that have the potential to generate billions in revenue. The problem is that they are in early-stage trials, so th more_horizontal

This Red-Hot Growth Stock Has Soared 885% in Just 12 Months

By The Motley Fool
June 8, 2023

This Red-Hot Growth Stock Has Soared 885% in Just 12 Months

Viking Therapeutics is a biotech with multiple potential blockbuster drugs in its portfolio. Encouraging trial results have made investors bullish abo more_horizontal


Search within

Pages Search Results: